CRP and Crohn disease: The American Gastroenterology Association guidelines for the role of biomarkers on the management of Crohn’s disease suggest a cut-off of CRP of 5 mg/L, below which active inflammation is unlikely and in certain circumstances advise clinicians use this cut-off to decide whether endoscopic evaluation should be performed [9].